PERCEPTIVE ADVISORS LLC Quant / Systematic

Location: New York, NY

CIK: 0001224962 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $6.662B (99.8% shares, 0.2% debt)

Holdings (109)

New Positions (29)

ASND ASCENDIS PHARMA A/S 4.7%
Value $310M Shares 1,163,721 Share Price $266.72 Est. Cost/Share — Unrealized @ Report Date —
KARD KARDIGAN INC 2.9%
Value $196M Shares 8,200,662 Share Price $23.85 Est. Cost/Share — Unrealized @ Report Date —
AVLN AVALYN PHARMACEUTICALS INC 1.3%
Value $88.07M Shares 2,675,296 Share Price $32.92 Est. Cost/Share — Unrealized @ Report Date —
BIIB BIOGEN INC 0.9%
Value $59.67M Shares 276,173 Share Price $216.06 Est. Cost/Share — Unrealized @ Report Date —
UNH UNITEDHEALTH GROUP INC 0.7%
Value $48.55M Shares 116,806 Share Price $415.63 Est. Cost/Share — Unrealized @ Report Date —
XBI SPDR SERIES TRUST 0.7%
Value $47.48M Shares 300,000 Share Price $158.25 Est. Cost/Share — Unrealized @ Report Date —
CRL CHARLES RIV LABS INTL INC 0.5%
Value $31.75M Shares 140,000 Share Price $226.79 Est. Cost/Share — Unrealized @ Report Date —
EYPT EYEPOINT INC 0.4%
Value $28.6M Shares 2,000,000 Share Price $14.30 Est. Cost/Share — Unrealized @ Report Date —
DHR DANAHER CORP DEL 0.4%
Value $24.76M Shares 130,000 Share Price $190.48 Est. Cost/Share — Unrealized @ Report Date —
CAPR CAPRICOR THERAPEUTICS INC 0.4%
Value $24.08M Shares 1,000,000 Share Price $24.08 Est. Cost/Share — Unrealized @ Report Date —
SLS SELLAS LIFE SCIENCES GROUP I 0.3%
Value $22.14M Shares 1,500,000 Share Price $14.76 Est. Cost/Share — Unrealized @ Report Date —
ANL ADLAI NORTYE LTD 0.3%
Value $20.62M Shares 1,793,190 Share Price $11.50 Est. Cost/Share — Unrealized @ Report Date —
NVCT NUVECTIS PHARMA INC 0.3%
Value $18.39M Shares 1,000,000 Share Price $18.39 Est. Cost/Share — Unrealized @ Report Date —
NAMS NEWAMSTERDAM PHARMA COMPANY 0.3%
Value $16.95M Shares 500,000 Share Price $33.89 Est. Cost/Share — Unrealized @ Report Date —
MIRM MIRUM PHARMACEUTICALS INC 0.2%
Value $13.51M Shares 115,391 Share Price $117.07 Est. Cost/Share — Unrealized @ Report Date —
CAPR CAPRICOR THERAPEUTICS INC 0.2%
Value $12.04M Shares 500,000 Share Price $24.08 Est. Cost/Share — Unrealized @ Report Date —
OSCR OSCAR HEALTH INC 0.2%
Value $11.41M Shares 400,000 Share Price $28.52 Est. Cost/Share — Unrealized @ Report Date —
SPTX SEAPORT THERAPEUTICS INC 0.2%
Value $10.86M Shares 500,000 Share Price $21.72 Est. Cost/Share — Unrealized @ Report Date —
BSX BOSTON SCIENTIFIC CORP 0.2%
Value $10.67M Shares 250,000 Share Price $42.68 Est. Cost/Share — Unrealized @ Report Date —
NTRA NATERA INC 0.1%
Value $9.416M Shares 34,689 Share Price $271.45 Est. Cost/Share — Unrealized @ Report Date —
ENGN ENGENE THERAPEUTICS INC 0.1%
Value $8.342M Shares 4,822,169 Share Price $1.73 Est. Cost/Share — Unrealized @ Report Date —
RACC RESEARCH ALLIANCE CORP III 0.1%
Value $8.025M Shares 750,000 Share Price $10.70 Est. Cost/Share — Unrealized @ Report Date —
CGEM CULLINAN THERAPEUTICS INC 0.1%
Value $7.766M Shares 426,478 Share Price $18.21 Est. Cost/Share — Unrealized @ Report Date —
QURE UNIQURE NV 0.1%
Value $7.738M Shares 168,000 Share Price $46.06 Est. Cost/Share — Unrealized @ Report Date —
MOBI MOBIA MED INC 0.1%
Value $7.017M Shares 523,654 Share Price $13.40 Est. Cost/Share — Unrealized @ Report Date —
OTLK OUTLOOK THERAPEUTICS INC 0.1%
Value $4.991M Shares 3,139,216 Share Price $1.59 Est. Cost/Share — Unrealized @ Report Date —
XERS XERIS BIOPHARMA HOLDINGS INC 0.1%
Value $3.699M Shares 467,013 Share Price $7.92 Est. Cost/Share — Unrealized @ Report Date —
BDSX BIODESIX INC 0.0%
Value $2.451M Shares 108,694 Share Price $22.55 Est. Cost/Share — Unrealized @ Report Date —
KPRX KIORA PHARMACEUTICALS INC 0.0%
Value $1.153M Shares 438,471 Share Price $2.63 Est. Cost/Share — Unrealized @ Report Date —

Increased Positions (28)

SYRE SPYRE THERAPEUTICS INC 5.8%
Value $383M (+101.0%) Shares 4,319,496 (+14.2%) Share Price $88.78 Est. Cost/Share — Unrealized @ Report Date —
RLAY RELAY THERAPEUTICS INC 4.0%
Value $264M (+172.0%) Shares 14,106,187 (+44.7%) Share Price $18.71 Est. Cost/Share — Unrealized @ Report Date —
TNGX TANGO THERAPEUTICS INC 1.6%
Value $106M (+524.4%) Shares 3,377,000 (+317.9%) Share Price $31.26 Est. Cost/Share — Unrealized @ Report Date —
RYTM RHYTHM PHARMACEUTICALS INC 4.3%
Value $287M (+39.1%) Shares 2,586,295 (+9.0%) Share Price $111.03 Est. Cost/Share — Unrealized @ Report Date —
RVMD REVOLUTION MEDICINES INC 1.5%
Value $98.81M (+292.9%) Shares 527,600 (+104.0%) Share Price $187.28 Est. Cost/Share — Unrealized @ Report Date —
MGTX MEIRAGTX HLDGS PLC 2.2%
Value $146M (+63.2%) Shares 10,786,658 (+4.5%) Share Price $13.51 Est. Cost/Share — Unrealized @ Report Date —
NRIX NURIX THERAPEUTICS INC 1.6%
Value $105M (+82.2%) Shares 4,320,422 (+16.4%) Share Price $24.26 Est. Cost/Share — Unrealized @ Report Date —
CORT CORCEPT THERAPEUTICS INC 0.5%
Value $34.64M (+1618.7%) Shares 398,385 (+696.8%) Share Price $86.95 Est. Cost/Share — Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS INC 1.5%
Value $103M (+45.7%) Shares 10,308,888 (+38.7%) Share Price $10.00 Est. Cost/Share — Unrealized @ Report Date —
STRO SUTRO BIOPHARMA INC 0.7%
Value $43.32M (+143.1%) Shares 1,304,846 (+82.4%) Share Price $33.20 Est. Cost/Share — Unrealized @ Report Date —
ADPT ADAPTIVE BIOTECHNOLOGIES COR 0.4%
Value $26.11M (+1133.6%) Shares 1,217,325 (+698.2%) Share Price $21.45 Est. Cost/Share — Unrealized @ Report Date —
CELC CELCUITY INC 5.0%
Value $334M (-6.3%) Shares 3,197,200 (+2.2%) Share Price $104.62 Est. Cost/Share — Unrealized @ Report Date —
ZYME ZYMEWORKS INC 1.6%
Value $109M (+24.4%) Shares 4,182,953 (+19.2%) Share Price $26.14 Est. Cost/Share — Unrealized @ Report Date —
AORT ARTIVION INC 0.6%
Value $39.04M (-34.9%) Shares 1,737,290 (+6.1%) Share Price $22.47 Est. Cost/Share — Unrealized @ Report Date —
IRTC IRHYTHM HOLDINGS INC 0.4%
Value $26.62M (+114.7%) Shares 223,766 (+113.1%) Share Price $118.95 Est. Cost/Share — Unrealized @ Report Date —
SION SIONNA THERAPEUTICS INC 0.6%
Value $39.81M (+50.8%) Shares 905,000 (+37.4%) Share Price $43.99 Est. Cost/Share — Unrealized @ Report Date —
EOLS EVOLUS INC 0.3%
Value $17.07M (+222.7%) Shares 2,459,285 (+91.1%) Share Price $6.94 Est. Cost/Share — Unrealized @ Report Date —
RAPP RAPPORT THERAPEUTICS INC 0.5%
Value $32.23M (+52.8%) Shares 773,342 (+14.8%) Share Price $41.67 Est. Cost/Share — Unrealized @ Report Date —
XFOR X4 PHARMACEUTICALS INC 0.6%
Value $37.05M (+33.1%) Shares 7,933,491 (+17.7%) Share Price $4.67 Est. Cost/Share — Unrealized @ Report Date —
CTMX CYTOMX THERAPEUTICS INC. 0.6%
Value $39.15M (-17.5%) Shares 10,439,185 (+3.4%) Share Price $3.75 Est. Cost/Share — Unrealized @ Report Date —
IONS IONIS PHARMACEUTICALS INC 0.7%
Value $44.88M (+18.6%) Shares 566,000 (+12.3%) Share Price $79.29 Est. Cost/Share — Unrealized @ Report Date —
DBVT DBV TECHNOLOGIES S A 0.4%
Value $27.11M (+34.6%) Shares 1,653,350 (+71.4%) Share Price $16.40 Est. Cost/Share — Unrealized @ Report Date —
SRZN SURROZEN INC 0.2%
Value $13.08M (+95.7%) Shares 503,985 (+119.7%) Share Price $25.95 Est. Cost/Share — Unrealized @ Report Date —
CRVS CORVUS PHARMACEUTICALS INC 0.6%
Value $39.85M (+18.8%) Shares 2,667,441 (+16.4%) Share Price $14.94 Est. Cost/Share — Unrealized @ Report Date —
AVTX AVALO THERAPEUTICS INC 0.1%
Value $4.062M (+94.8%) Shares 219,813 (+57.4%) Share Price $18.48 Est. Cost/Share — Unrealized @ Report Date —
OCS OCULIS HOLDING AG 0.2%
Value $11.22M (-14.6%) Shares 808,827 (+63.8%) Share Price $13.87 Est. Cost/Share — Unrealized @ Report Date —
TENX TENAX THERAPEUTICS INC 0.4%
Value $24.73M (+6.8%) Shares 1,700,000 (+17.4%) Share Price $14.55 Est. Cost/Share — Unrealized @ Report Date —
SABS SAB BIOTHERAPEUTICS INC 0.4%
Value $25.85M (+4.9%) Shares 6,627,501 (+3.0%) Share Price $3.90 Est. Cost/Share — Unrealized @ Report Date —

Exited Positions (14)

ASND ASCENDIS PHARMA A/S 5.3%
Value $350M Shares 1,531,421 Share Price $228.73 Est. Cost/Share — Unrealized @ Report Date —
CNTA CENTESSA PHARMACEUTICALS PLC 3.1%
Value $209M Shares 5,258,903 Share Price $39.72 Est. Cost/Share — Unrealized @ Report Date —
ENGN ENGENE HOLDINGS INC 0.6%
Value $39.69M Shares 5,827,506 Share Price $6.81 Est. Cost/Share — Unrealized @ Report Date —
DAWN DAY ONE BIOPHARMACEUTICALS I 0.6%
Value $37.64M Shares 1,755,799 Share Price $21.44 Est. Cost/Share — Unrealized @ Report Date —
DRUG BRIGHT MINDS BIOSCIENCES INC 0.4%
Value $27.55M Shares 377,544 Share Price $72.97 Est. Cost/Share — Unrealized @ Report Date —
BLTE BELITE BIO INC 0.4%
Value $24.23M Shares 151,979 Share Price $159.44 Est. Cost/Share — Unrealized @ Report Date —
EVMN EVOMMUNE INC 0.2%
Value $10.31M Shares 448,350 Share Price $22.99 Est. Cost/Share — Unrealized @ Report Date —
NMRA NEUMORA THERAPEUTICS INC. 0.1%
Value $9.953M Shares 5,104,097 Share Price $1.95 Est. Cost/Share — Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 0.1%
Value $8.57M Shares 65,050 Share Price $131.74 Est. Cost/Share — Unrealized @ Report Date —
IRD OPUS GENETICS INC 0.1%
Value $8.353M Shares 1,835,842 Share Price $4.55 Est. Cost/Share — Unrealized @ Report Date —
OCUL OCULAR THERAPEUTIX INC 0.1%
Value $4.235M Shares 500,000 Share Price $8.47 Est. Cost/Share — Unrealized @ Report Date —
IKT INHIBIKASE THERAPEUTICS INC 0.1%
Value $3.889M Shares 2,315,000 Share Price $1.68 Est. Cost/Share — Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 0.0%
Value $3.257M Shares 80,956 Share Price $40.23 Est. Cost/Share — Unrealized @ Report Date —
PTN PALATIN TECHNOLOGIES INC 0.0%
Value $1.079M Shares 61,945 Share Price $17.42 Est. Cost/Share — Unrealized @ Report Date —

Decreased Positions (26)

TVTX TRAVERE THERAPEUTICS INC 3.2%
Value $213M (+73.2%) Shares 3,752,574 (-9.4%) Share Price $56.81 Est. Cost/Share — Unrealized @ Report Date —
ORKA ORUKA THERAPEUTICS INC 1.9%
Value $128M (+87.0%) Shares 1,345,063 (-3.6%) Share Price $95.17 Est. Cost/Share — Unrealized @ Report Date —
ROIV ROIVANT SCIENCES LTD 4.3%
Value $286M (+24.7%) Shares 8,085,461 (-2.4%) Share Price $35.39 Est. Cost/Share — Unrealized @ Report Date —
APGE APOGEE THERAPEUTICS INC 2.6%
Value $174M (+33.9%) Shares 1,308,113 (-15.1%) Share Price $132.73 Est. Cost/Share — Unrealized @ Report Date —
EWTX EDGEWISE THERAPEUTICS INC 2.7%
Value $178M (+27.5%) Shares 4,373,974 (-1.1%) Share Price $40.63 Est. Cost/Share — Unrealized @ Report Date —
NAUT NAUTILUS BIOTECHNOLOGY INC 0.3%
Value $21.76M (-55.5%) Shares 11,634,211 (-7.6%) Share Price $1.87 Est. Cost/Share — Unrealized @ Report Date —
ABVX ABIVAX SA 0.1%
Value $9.861M (-73.1%) Shares 74,000 (-77.5%) Share Price $133.26 Est. Cost/Share — Unrealized @ Report Date —
INBX INHIBRX BIOSCIENCES INC 1.8%
Value $123M (+26.8%) Shares 1,297,763 (-10.0%) Share Price $94.75 Est. Cost/Share — Unrealized @ Report Date —
DYN DYNE THERAPEUTICS INC 0.9%
Value $59.73M (-29.4%) Shares 2,689,235 (-42.4%) Share Price $22.21 Est. Cost/Share — Unrealized @ Report Date —
GH GUARDANT HEALTH INC 0.1%
Value $6.2M (-77.6%) Shares 41,327 (-86.2%) Share Price $150.03 Est. Cost/Share — Unrealized @ Report Date —
ISRG INTUITIVE SURGICAL INC 0.3%
Value $20.63M (-47.6%) Shares 51,884 (-39.3%) Share Price $397.68 Est. Cost/Share — Unrealized @ Report Date —
IMVT IMMUNOVANT INC 0.8%
Value $52.3M (+31.8%) Shares 1,357,383 (-15.0%) Share Price $38.53 Est. Cost/Share — Unrealized @ Report Date —
VRDN VIRIDIAN THERAPEUTICS INC 0.2%
Value $10.69M (-53.3%) Shares 581,980 (-50.3%) Share Price $18.37 Est. Cost/Share — Unrealized @ Report Date —
AXGN AXOGEN INC 0.2%
Value $11.42M (-50.6%) Shares 247,312 (-64.5%) Share Price $46.19 Est. Cost/Share — Unrealized @ Report Date —
IVVD INVIVYD INC 0.2%
Value $16.13M (-40.5%) Shares 18,490,636 (-11.4%) Share Price $0.87 Est. Cost/Share — Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 1.8%
Value $120M (-7.2%) Shares 981,879 (-20.2%) Share Price $122.58 Est. Cost/Share — Unrealized @ Report Date —
BBNX BETA BIONICS INC 0.2%
Value $13.05M (+54.5%) Shares 832,944 (-1.2%) Share Price $15.67 Est. Cost/Share — Unrealized @ Report Date —
PHAT PHATHOM PHARMACEUTICALS INC 0.1%
Value $5.772M (-43.8%) Shares 532,000 (-42.5%) Share Price $10.85 Est. Cost/Share — Unrealized @ Report Date —
AXSM AXSOME THERAPEUTICS INC. 0.4%
Value $28.99M (+14.4%) Shares 118,450 (-21.0%) Share Price $244.77 Est. Cost/Share — Unrealized @ Report Date —
TWST TWIST BIOSCIENCE CORP 0.1%
Value $3.787M (-46.9%) Shares 36,812 (-75.5%) Share Price $102.88 Est. Cost/Share — Unrealized @ Report Date —
ADMA ADMA BIOLOGICS INC 0.0%
Value $952K (-77.4%) Shares 113,765 (-75.7%) Share Price $8.37 Est. Cost/Share — Unrealized @ Report Date —
BLLN BILLIONTOONE INC 0.2%
Value $10.42M (+43.7%) Shares 86,812 (-5.4%) Share Price $119.98 Est. Cost/Share — Unrealized @ Report Date —
ANRO ALTO NEUROSCIENCE INC 0.6%
Value $42.49M (-6.0%) Shares 1,609,893 (-19.9%) Share Price $26.39 Est. Cost/Share — Unrealized @ Report Date —
PALI PALISADE BIO INC 0.3%
Value $17.61M (+12.7%) Shares 8,425,065 (-5.6%) Share Price $2.09 Est. Cost/Share — Unrealized @ Report Date —
RGEN REPLIGEN CORP 0.5%
Value $33.87M (+2.5%) Shares 248,212 (-11.5%) Share Price $136.44 Est. Cost/Share — Unrealized @ Report Date —
CPIX CUMBERLAND PHARMACEUTICALS I 0.0%
Value $628K (-1.8%) Shares 96,982 (-50.8%) Share Price $6.48 Est. Cost/Share — Unrealized @ Report Date —

Unchanged Positions (26)

AMLX AMYLYX PHARMACEUTICALS INC 2.2%
Value $150M Shares 8,334,882 Share Price $17.96 Est. Cost/Share — Unrealized @ Report Date —
NUVL NUVALENT INC 2.9%
Value $195M Shares 1,580,505 Share Price $123.50 Est. Cost/Share — Unrealized @ Report Date —
SLDB SOLID BIOSCIENCES INC 1.8%
Value $119M Shares 11,906,646 Share Price $9.99 Est. Cost/Share — Unrealized @ Report Date —
PRAX PRAXIS PRECISION MEDICINES I 10.2%
Value $682M Shares 2,035,986 Share Price $334.79 Est. Cost/Share — Unrealized @ Report Date —
MRNA MODERNA INC 1.1%
Value $70.03M Shares 1,000,000 Share Price $70.03 Est. Cost/Share — Unrealized @ Report Date —
AVR ANTERIS TECHNOLOGIES GLOBAL 0.5%
Value $33.74M Shares 3,425,476 Share Price $9.85 Est. Cost/Share — Unrealized @ Report Date —
JAZZ JAZZ PHARMACEUTICALS PLC 0.6%
Value $40.96M Shares 170,000 Share Price $240.97 Est. Cost/Share — Unrealized @ Report Date —
OMDA OMADA HEALTH INC 0.3%
Value $17.26M Shares 786,330 Share Price $21.95 Est. Cost/Share — Unrealized @ Report Date —
ADGM ADAGIO MED HLDGS INC 0.1%
Value $6.44M Shares 9,876,586 Share Price $0.65 Est. Cost/Share — Unrealized @ Report Date —
CTNM CONTINEUM THERAPEUTICS INC 0.3%
Value $20.58M Shares 1,255,592 Share Price $16.39 Est. Cost/Share — Unrealized @ Report Date —
IMTX IMMATICS N.V 1.6%
Value $105M Shares 10,383,456 Share Price $10.13 Est. Cost/Share — Unrealized @ Report Date —
LONA LEONABIO INC 0.3%
Value $17.09M Shares 1,859,322 Share Price $9.19 Est. Cost/Share — Unrealized @ Report Date —
RVMDW REVOLUTION MEDICINES INC 0.0%
Value $2.345M Shares 250,000 Share Price $9.38 Est. Cost/Share — Unrealized @ Report Date —
EDSA EDESA BIOTECH INC 0.1%
Value $4.579M Shares 563,239 Share Price $8.13 Est. Cost/Share — Unrealized @ Report Date —
AGMB AGOMAB THERAPEUTICS NV 0.1%
Value $7.788M Shares 600,000 Share Price $12.98 Est. Cost/Share — Unrealized @ Report Date —
— CELCUITY INC 0.2%
Value $14.63M Shares 6,500,000 Share Price $2.25 Est. Cost/Share — Unrealized @ Report Date —
OM OUTSET MED INC 0.1%
Value $3.6M Shares 833,333 Share Price $4.32 Est. Cost/Share — Unrealized @ Report Date —
OBIO ORCHESTRA BIOMED HLDGS INC 0.3%
Value $21.74M Shares 5,037,906 Share Price $4.31 Est. Cost/Share — Unrealized @ Report Date —
CNTB CONNECT BIOPHARMA HLDGS LTD 0.0%
Value $1.887M Shares 792,696 Share Price $2.38 Est. Cost/Share — Unrealized @ Report Date —
XGN EXAGEN INC 0.0%
Value $534K Shares 114,893 Share Price $4.65 Est. Cost/Share — Unrealized @ Report Date —
MDLN MEDLINE INC 0.0%
Value $1.104M Shares 28,000 Share Price $39.44 Est. Cost/Share — Unrealized @ Report Date —
GLTO DAMORA THERAPEUTICS INC 0.5%
Value $31.81M Shares 1,223,000 Share Price $26.01 Est. Cost/Share — Unrealized @ Report Date —
CBIO CRESCENT BIOPHARMA INC. 0.1%
Value $3.725M Shares 206,942 Share Price $18.00 Est. Cost/Share — Unrealized @ Report Date —
COGT COGENT BIOSCIENCES INC 0.1%
Value $4.686M Shares 121,082 Share Price $38.70 Est. Cost/Share — Unrealized @ Report Date —
ENSC ENSYSCE BIOSCIENCES INC 0.0%
Value $25,133 Shares 86,666 Share Price $0.29 Est. Cost/Share — Unrealized @ Report Date —
SRZNW SURROZEN INC 0.0%
Value $2,750 Shares 166,666 Share Price $0.02 Est. Cost/Share — Unrealized @ Report Date —